Evidence map›Paper›PMID 42907733›Full record

ArticleSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society2026

Activation of TLR4 promotes oxidative inflammation via NADPH oxidase signaling in platelets of subjects with autism spectrum disorder.

Mohammad M Algahtani, Sheikh F Ahmad, Naif O Al-Harbi, Laila Y Al-Ayadhi, Khalid Alhazzani, Sabry M Attia, Ahmed Z Alanazi, Saleh A Bakheet, Ahmed Nadeem

Abstract read
In one paragraph

Article in Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mohammad M AlgahtaniDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. mohgahtani@ksu.edu.sa.
Sheikh F AhmadDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Naif O Al-HarbiDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Laila Y Al-AyadhiDepartment of Physiology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Khalid AlhazzaniDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Sabry M AttiaDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Ahmed Z AlanaziDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Saleh A BakheetDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Ahmed NadeemDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. anadeem@ksu.edu.sa.ORCID http://orcid.org/0000-0003-2038-8367

Funding

King Saud University ORF-2026-1788
6 · The paper itself

Abstract

Autism spectrum disorder (ASD) is a complex neurobehavioral disorder where both immune system and neurological dysregulations are known to play crucial roles. Platelets are known to play key roles in systemic oxidative inflammation through production of oxidants. However, there is still scarcity of data regarding the role of blood platelets in ASD subjects. Platelets are known to express innate receptors such as toll-like receptor 4 (TLR4), transcription factors such as NFkB, and oxidative enzymes such as NADPH oxidase (NOX2), however the molecular mechanisms in generation of oxidative inflammation in platelets of ASD subjects have not been investigated until now. Therefore, this study was aimed at investigating expression of TLR4, NFkB, NOX2, reactive oxygen species (ROS) and lipid peroxides (a marker of oxidative damage on lipid membranes) in platelets of ASD children (n = 27) and typically developing children (TDC; n = 22) through molecular and biochemical analyses. Further, correlation analysis was carried out with severity of the disease. Our data showed an upregulated expression of TLR4 and p-NFkB in ASD platelets as compared to TDC platelets. Further, elevated TLR4/ NFkB signaling was linked with elevated NOX2-derived ROS and oxidative stress. It was confirmed by the utilization of NFkB and NOX2 inhibitors which caused reduction in LPS-induced ROS and oxidative stress in ASD platelets. Further, there was positive correlation between platelet oxidative stress and severity of the disease. Our data suggests that elevated TLR4/ NFkB signaling in platelets of ASD subjects might predispose them to increased systemic oxidative inflammation through NOX-2 derived ROS generation and oxidative stress.

Indexed as

AutismNADPH oxidaseOxidative inflammationPlateletsTLR4

Identifiers

PMID42907733
PMCPMC13687475

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.